Glenmark, Particle Sciences to develop generic cancer drug - The Economic Times
Abraxane (Albumin-bound Paclitaxel for Injectable Suspension): Uses, Dosage, Side Effects, Interactions, Warning
FDA Mostly Shoots Down BMS' Petition to Halt Abraxane Generics | 2021-07-08 | FDAnews
Chemotherapy-Related Skin Toxicities - Cancer Therapy Advisor
Allergan Confirms Generic Abraxane® Patent Challenge - Chemdiv
Paclitaxel– Protein Bound
Panacea Biotec gets US nod for generic version of cancer drug Abraxane – Ultra News
Allergan files ANDA to the FDA for generic Abraxane
Abraxis Pharma Products 68817013450 - McKesson Medical-Surgical
New Generic will Cut into BMS's Top-Earning Cancer Drug | BioSpace
BMS' Revlimid revenues hit by onset of generics for the cancer drug
US co Abraxis denied patent on cancer drug - Times of India
Dr. Reddy's launches generic of Takeda's cancer drug Velcade in US | Seeking Alpha
Glenmark, Particle Sciences ink deal to develop generic cancer drug Abraxane | Mint
Panacea Biotec stock jumps 6% on settlement agreement with Celgene for Abraxane generic
Stephen V Liu, MD on Twitter: "Just learned that abraxane is on manufacturer backorder with no release date. Wondering if drug shortages are the downstream effect of supply chain issues and is
FDA Shuts The Door On Celgene's Abraxane Petition :: Generics Bulletin
F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer - The New York Times
Abraxane for the Treatment of Late-Stage Pancreatic Cancer - Clinical Trials Arena
Generics | Drug Store News
CENTER FOR DRUG EVALUATION AND RESEARCH
Abraxane - Uphar Speciality Pharma
Abraxane for the Treatment of Late-Stage Pancreatic Cancer - Clinical Trials Arena
Medical Tidbits, Allergan Confirms Generic Abraxane® Patent Challenge | MedCareer News
Apotex Launches Apparent First Abraxane Generic – With Little Fanfare :: Generics Bulletin
